Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.2B | 8.3B | 8.4B | 8.3B |
Cost of revenue | 6.2B | 6.3B | 6.4B | 6.2B |
Gross profit | 2.0B | 2.0B | 2.0B | 2.1B |
Operating expense | ||||
Research & development | 326.5M | 341.8M | 323.8M | 292.8M |
Selling general and admin | 610.7M | 844.7M | 833.1M | 874.6M |
Other operating expenses | — | — | — | — |
Operating income | 1.1B | 814.0M | 881.4M | 960.8M |
Non operating interest income | ||||
Income | 13.6M | 24.0M | 13.8M | 34.2M |
Expense | 16.7M | 16.1M | 10.5M | 13.9M |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 945.1M | 1.2B | 1.2B |
Tax provision | 309.7M | 217.0M | 228.2M | 259.5M |
Net income | 921.6M | 728.1M | 946.7M | 937.1M |
Basic EPS | 3.9 | — | 4.0 | 3.9 |
Diluted EPS | 3.8 | — | 3.9 | 3.9 |
Basic average shares | 240.1M | — | 240.3M | 239.9M |
Diluted average shares | 242.6M | — | 242.7M | 242.3M |
EBITDA | 1.4B | 1.1B | 1.3B | 1.4B |
Net income from continuing op. | 1.2B | 945.1M | 1.2B | 1.2B |
Minority interests | 2.8M | 4.8M | 2.4M | -1.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |